New podcasts from advocacy organization Phaware will highlight treatment advances in pulmonary hypertension tied to ...

Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people with PAH.

Pulmonary hypertension is linked to an increased risk for sleep apnea and structural brain changes at the genetic level, a ...

The FDA is poised to issue a final decision on the approval and marketing of Yutrepia, an inhaled dry powder formulation of ...

Tech improvements have benefited the chronic illness community, writes columnist Anna Jeter, who shares things she uses to manage her health.

A higher diameter ratio on CT scans between the right ventricle and left ventricle, which are the heart’s lower chambers, independently predicts major adverse cardiovascular events in people with ...

A larger diameter of the main pulmonary artery predicts poorer outcomes in pulmonary arterial hypertension (PAH) patients, a study found.